
Gastroenterologist #IBD specialist at @hureinasofia @IMIBIC Help others grow their abilities and celebrate life. IBD education at https://nitter.cf/t.co/4V0xhhdIti
Edinburgh, Scotland
Joined August 2011
- Tweets13.4K
- Following998
- Followers7.2K
- Likes21.6K
Pinned Tweet
🌟Ever found yourself doubting about IBD new drugs doses? or forgetting Thiopurine metabolism details?
I've been there too
So I thought it could help having "IBD Cheat Sheets" and that is what I did:
ibd-eii.com/ibdcheatsheet
I hope it helps as much as it helps me
1/2
#IBD
Replying to @JoanaTo62523004
@JoanaTo62523004
EIMs in #IBD . How does our therapies stack up
Fantastic practical talk 🙏🏼
Useful resource from @Bealoquebea in @FrontGastro_BMJ t of
fg.bmj.com/content/flgastro/…
Beatriz Gros retweeted
"Does changing the microbiome actually improve health?"
Danny Lennon opened with that question, and I spent an hour trying to answer it honestly.
Sigma Nutrition Radio #625, out today.
sigmanutrition.com/podcast/e…
Beatriz Gros retweeted
Perianal Crohn’s: which fistula can you actually close?
Only one: a single tract, no proctitis.
Sepsis first (drain + seton), then anti-TNF, then LIFT or flap - both heal 50-60%.
1 min with @AmyLightnerMD #THRIVE2027 👇
Free until tomorrow, 27 Oct - link below
@escp_tweets
Excited to share our latest publication in @BMJDigitalHealth! 🚀
In just 6 months, @ChatIBDapp reached 913 users across 69 countries, generating 7,222 messages in 28 languages 🌍
A first step towards guideline-grounded AI in #IBD care. Formal validation is next!
Congrats to @drshaunchuah the brilliant mind behind this and to Nik Plevris
doi.org/10.1136/bmjcdh-2026-…
Beatriz Gros retweeted
Is proximal small bowel Crohn worse than distal bcs the Tx is less effective there?
Well, No...
In our @sheba_medical #capsule study now published in @AGA_CGH , biologics induced similar mucosal healing in proximal vs distal SB.
@OffirU @HelmsleyTrust
cghjournal.org/article/S1542…
Beatriz Gros retweeted
Mufemilast, oral PDE4 inhibitor, phase 2 trial results presented at UEGWeek @my_ueg
Beatriz Gros retweeted
Symptomatic remission data of TUSCANY-2 trial (Afimkibart, anti-TL1A monoclonal antibody, in ulcerative colitis) presented at @my_ueg UEGWeek
Beatriz Gros retweeted
Agree that the exact message is tough to sort out given that the endo and histo tracked so closely
Beatriz Gros retweeted
From admiring their work to sharing this moment. Truly inspiring to be alongside these incredible women and leaders in IBD! 👩🏻⚕️❤️✨🇵🇪
#UEGWeek2026 #IBD #YOGI
Beatriz Gros retweeted
So Honoured for The prize for best abstract for our @GastroCHUSv2 @idis_research @santiagosergas Study “A PHASE 2A STUDY TO EVALUATE SAFETY, PHARMACOK AND CLINICAL EFFICACY OF ORAL TREATMENT WITH MBF-118 IN PATIENTS WITH FIBROSTENOSING CROHN’S DISEASE” @my_ueg #UEGWeek2026 #UEGW
Beatriz Gros retweeted
Replying to @Bealoquebea
@Bealoquebea Thank you so much for all your work and dedication to the young GI generation. It truly has been a pleasure working with you.
This was the last UEG congress being part of the Young talent group of the UEG
These two years have been extraordinary, I have met incredible people, collaborated in different projects and learnt a lot from so many different things, I can only say THANK YOU to @my_ueg and to the fantastic people in the group
I will always be in debt, thank you for the opportunity to represent the young generation of GI’s
Beatriz Gros retweeted
1/7 One gut-derived bile acid, isoUDCA, statistically mediates 19.6% of the female advantage against chronic liver disease (n = 9,254: 6,604 health-screened, 2,650 CLD).
cell.com/cell/fulltext/S0092…
Beatriz Gros retweeted
Realizable o mejor factible, en el contexto que lo mencionáis. Porque hay también un contexto legal, y ahí sería más complicado para mí encontrar la equivalencia más exacta.
I can’t think of anyone more deserving of this Rising Star Award than Nuru
Beyond his extraordinary scientific contributions, he is genuinely one of the most generous people in IBD. He constantly creates opportunities, gives visibility, and makes space for those of us who may not have the same support or opportunities
He is leading an unprecedented shift in how clinical trials are designed, bringing a level of passion, vision, and endless energy that is truly inspiring
I couldn’t be prouder of him, not only for what he is achieving, but for the way he brings others along with him. So well deserved!
Beatriz Gros retweeted
One of a kind anti-fibrotic, Ontunisertib. Results from OLE presented by @IBD_FloMD.
➡️ Well tolerated, no safety concerns
➡️No stricture progression on MRE
➡️3% EBD/✂️; only 1 EBD/48 weeks
@AnjaMD_IBD @JordiRimola @RPanaccione @BettenworthDb #STARconsortium
#UEGWeek @my_ueg
Beatriz Gros retweeted
PROFILE trial 5 year follow up results presented at UEGWeek @my_ueg ‘top- down’ treatment with Infliximab and Azathioprine reduced unplanned hospitalisation and surgery for patients with moderate to severe Crohn’s disease














































